|
||
|
| Home |  |
Firm Description | |
Sectors Covered | |
Completed Transactions | |
Testimonials | |
Principals | |
M&A Report and Publications |
|
Contact Us | |
| Acquiring Party | Wound Management Technologies, Inc. (WNDM.OB), a manufacturer and distributor biomaterial wound care products. |
|---|---|
| Transferring Party | Resorbable Orthopedics LLC, a manufacturer of biomaterial orthopedic products. |
| Sector | Medical Devices |
| Date | September 30, 2009 |
| Analysis Adds complementary orthopedic biomaterials products to WMT's portfolio. The target has a patented bone wax and delivery system addressing ‘bone wax granuloma’ and bone wound healing. A stock merger of two very small companies seeking synergies in addressing the orthopedic and woundccare biomaterials market estimated at $10b. WMT is in early stage of commercializing its products, and this is the second stock deal it announced in Q3. | |
The Walden Group is a leading healthcare investment banking firm specializing in mergers, acquisitions and strategic transactions. It also invests its own funds and, together with its expert operational partners, provides value-added services to help special companies reach critical milestones. This information is copyright © 2004-2010 The Walden Group, Inc. This information is provided as a service to the public but remains the intellectual property of The Walden Group, Inc and may not be reproduced in any manner without the written permission of The Walden Group, Inc. The information contained in the transactions table was derived from publicly available and other sources. Transaction analysis and other information are based, in part, upon public comments, Walden Group research and judgments, and reporting and research of others. The information is not intended to be relied upon as pronouncements by the transaction participants or for any other reason. | |